Nuvectis Pharma (NVCT) Times Interest Earned (2021 - 2026)
Nuvectis Pharma (NVCT) reported Times Interest Earned of -$5.72 for Q1 2026, down 85.39% on a YoY basis from -$39.17 in Q1 2025, and up 22.55% sequentially from -$7.39 in Q4 2025.
Nuvectis Pharma (NVCT) Times Interest Earned (2021 - 2026) Analysis & Trends
Nuvectis Pharma (NVCT) has 6 years of Times Interest Earned data on file, last reported at -$5.72 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 85.39% year-over-year to -$5.72; the trailing twelve-month figure through Mar 2026 stood at -$25.84 (down 121.75% YoY), and the FY2025 full-year result was -$26.74, down 2531.5% from the prior year.
- Times Interest Earned climbed to -$5.72 in Q1 2026, from -$7.39 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.33 in Q4 2024 to a low of -$15.65 in Q3 2025.
- A 5-year average of -$3.76 and a median of -$2.15 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned soared 88.35% in 2023 and slumped 2137.13% in 2025, its largest moves.
- Tracing NVCT's Times Interest Earned over 5 years: stood at -$0.79 in 2022, then surged by 40.07% to -$0.47 in 2023, then surged by 30.3% to -$0.33 in 2024, then tumbled by 2137.13% to -$7.39 in 2025, then gained by 22.55% to -$5.72 in 2026.
- Business Quant data shows NVCT's Times Interest Earned at -$5.72 in Q1 2026, -$7.39 in Q4 2025, and -$15.65 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Nuvectis Pharma | 453.54 Mn | 453.54 Mn | - | -5.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.72 |
| Dec 31, 2025 | -7.39 |
| Sep 30, 2025 | -15.65 |
| Jun 30, 2025 | -6.58 |
| Mar 31, 2025 | -3.09 |
| Dec 31, 2024 | -0.33 |
| Sep 30, 2024 | -7.36 |
| Jun 30, 2024 | -7.66 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.50 |
| Jun 30, 2023 | -1.45 |
| Mar 31, 2023 | -0.35 |
| Dec 31, 2022 | -0.79 |
| Sep 30, 2022 | -2.15 |
| Jun 30, 2022 | -0.96 |
| Mar 31, 2022 | -2.98 |
| Dec 31, 2021 | -0.65 |